Quoin Pharmaceuticals Ltd – ADR (NASDAQ:QNRX) shares are trading lower by 42.82% to $0.68 Wednesday morning. The company announced pricing of its $7 million public offering.
What Else?
The offering represents 4,950,000 American Depositary Shares at a purchase price of $1.00 per ADS and pre-funded warrants of 2,050,000 American Depositary Shares at a per pre-funded warrant price of $0.9999.
Quoin Pharmaceuticals says the closing of the offering is expected to occur on or about February 24, subject to the satisfaction of customary closing conditions.
See Also: Why Keysight Technologies Stock Is Trading Lower
The company intends to use the net proceeds from the offering for general corporate purposes.
According to data from Benzinga Pro, QNRX has a 52-week high of $28.11 and a 52-week low of $1.11.
